Kaishaoye Health (00876): The Chinese stock abbreviation will be changed to “Qinghai Biopharmaceutical”

Zhitongcaijing · 3d ago

Zhitong Finance App News, Kaisa Health (00876) issued an announcement. Following shareholders' approval of the change of the company name at the special shareholders' meeting, the company's name has been changed from “Kaisa Health Group Holdings Limited” to “Qinghai Biotech Pharmaceutical Group Limited”, and “Qinghai Biopharmaceutical Group Co., Ltd.” has been adopted as the company's second Chinese name to replace the previous Chinese name “Kaisa Health “Group Holdings Limited”, both effective September 3, 2026, are based on the certificate of name change and certificate of second name issued by the Registrar of Companies of Bermuda on September 3, 2026. The Registrar of Hong Kong Companies issued a certificate of registration for a change of name for a registered non-Hong Kong company on September 18, 2026, confirming that the company's new English and Chinese name (change of company name) was registered in Hong Kong in accordance with Part 16 of the Companies Ordinance, Chapter 622 of the Laws of Hong Kong.

After changing the company name, the English stock abbreviation for shares traded on the Hong Kong Stock Exchange will be changed from “KAISA HEALTH” to “QH BIO PHARMA”, while the Chinese stock abbreviation will be changed from “Kaisa Health” to “Qinghai Biopharmaceutical”, effective from 9:00 a.m. on September 28, 2026. The Company's stock code on the Hong Kong Stock Exchange remains unchanged and remains “876”.